Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies-Reference-Cited by-同舟云学术

Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

Published:2020-04-30 Issue:5 Volume:2 Page:294-299
ISSN:2578-5745
Container-title:ACR Open Rheumatology
language:en
Short-container-title:ACR Open Rheuma

Author:

Deodhar Atul A.¹^ORCID,Miceli‐Richard Corine²,Baraliakos Xenofon³,Marzo‐Ortega Helena⁴,Gladman Dafna D.⁵,Blanco Ricardo⁶,Das Gupta Ayan⁷,Martin Ruvie⁸,Safi Jorge⁸,Porter Brian⁸,Shete Abhijit⁹,Rosenbaum James T.¹⁰^ORCID

Affiliation:

1. Oregon Health & Science University Portland

2. Paris Descartes University, Hôpital Cochin, Assistance Publique–Hôpitaux de Paris, and European League Against Rheumatism Center of Excellence Paris France

3. Ruhr‐University Bochum Bochum Germany

4. Leeds Teaching Hospitals NHS Trust and University of Leeds Leeds UK

5. Toronto Western Hospital Toronto Canada

6. Hospital Universitario Marqués de Valdecilla Santander Spain

7. Novartis Healthcare Private Limited Hyderabad India

8. Novartis Pharmaceuticals Corporation East Hanover New Jersey

9. Novartis Pharma AG Basel Switzerland

10. Oregon Health & Science University and Legacy Devers Eye Institute Portland

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11139